Vitamin D Testing Market Set to Reach USD 1.79 Billion by 2032

Introduction

The global Vitamin D Testing Market is projected to grow significantly from USD 851 Million in 2022 to an estimated USD 1,786.0 Million by 2032, marking a compound annual growth rate (CAGR) of 7.90% during the forecast period from 2023 to 2032. This market expansion is driven by increasing awareness of vitamin D deficiency, advancements in testing technologies, and a growing emphasis on preventive healthcare measures.

Several factors contribute to the market’s growth. The rising prevalence of diseases such as osteoporosis and thyroid disorders, which are often linked to inadequate vitamin D levels, underscores the need for efficient vitamin D testing. Technological advancements, particularly in the method of liquid chromatography-mass spectrometry (LC-MS), have enhanced the accuracy and reliability of vitamin D tests, making them the preferred choice in clinical settings. The 25-hydroxy vitamin D test, recognized for its effectiveness, remains the most common test due to its ability to accurately assess vitamin D levels​.

However, the market faces challenges such as the high variability of test results, particularly with methods like radioimmunoassay and ELISA, which can hinder the determination of vitamin D status​. Moreover, the COVID-19 pandemic temporarily disrupted healthcare services, including routine vitamin D testing, although the market is expected to recover as the importance of immune health gains recognition post-pandemic​.

Danaher Corporation, a key player in the science and technology sector, has continued its strategic expansion through acquisitions, notably in the life sciences market. In a significant recent development, Danaher announced a definitive agreement to acquire Abcam plc, a leading provider of protein consumables. This acquisition, valued at approximately $5.7 billion, is expected to close by mid-2024, pending regulatory and shareholder approvals​.

In the domain of Vitamin D testing specifically, bioMérieux launched the VIDAS® 25 OH Vitamin D Total assay in 2013. This diagnostic tool is utilized to measure total vitamin D levels in human serum and plasma, providing results within 40 minutes using the ELFA technology. The VIDAS platform, upon which this test is run, is highly regarded for its reliability and has a significant global installation base across clinical laboratories. This development has bolstered bioMérieux’s capability to address the clinical needs for in-house Vitamin D testing, previously reliant on external reference laboratories​.

Key Takeaways

• The Global Vitamin D Testing Market is expanding, with a projected CAGR of 7.90%, driven by increased awareness and a rising incidence of vitamin D deficiencies.
• The 25-hydroxy vitamin D test, as the primary method for assessing vitamin D levels, captures the largest share of the market.
• Clinical testing dominates the vitamin D testing applications, with diagnostic laboratories emerging as the primary end-users.
• Vitamin D testing is crucial for diagnosing osteoporosis and rickets, diseases directly linked to vitamin D deficiency.
• Liquid Chromatography-Mass Spectrometry (LC-MS) leads in testing accuracy for vitamin D metabolites, making it the preferred technique.
• North America is at the forefront of the vitamin D testing market, propelled by robust awareness campaigns and FDA-approved testing kits.
• Major industry players include F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., and Abbott, with opportunities for market leadership through technological innovations.
• DiaSorin S.p.A. saw a 25.9% drop in sales for vitamin D testing products in 2022.
• Abbott reported a 3.9% decrease in core laboratory revenue in 2022, a downturn attributed to disruptions caused by COVID-19.

Vitamin D Testing Statistics

• Global Prevalence of Vitamin D Deficiency:
  • Approximately 1 billion people worldwide have vitamin D deficiency.
  • 50% of the population has vitamin D insufficiency.
• High-Risk Populations:
  • In the United States, about 50% to 60% of nursing home residents and hospitalized patients had vitamin D deficiency.
  • In the adult population of the United States, 35% are vitamin D deficient.
  • In the elderly population of the United States, 61% are vitamin D deficient.
• Prevalence in Different Ethnic Groups:
  • In the United States, 47% of African American infants and 56% of Caucasian infants have vitamin D deficiency.
  • Over 90% of infants in Iran, Turkey, and India have vitamin D deficiency.
  • In the adult population of Pakistan, India, and Bangladesh, over 80% are vitamin D deficient.
• Recommended Serum Levels:
  • Optimal serum levels of 25-hydroxyvitamin D are still controversial, but the International Society for Clinical Densitometry and the International Osteoporosis Foundation recommend minimum serum levels of 30 ng/mL.
  • Serum levels above 100 ng/mL may pose a potential risk of toxicity due to secondary hypercalcemia.
• Treatment and Management:
  • Initial supplementation for 8 weeks with Vitamin D3, either 6,000 IU daily or 50,000 IU weekly, can be considered for adults.
  • Once the serum 25-hydroxyvitamin D level exceeds 30 ng/mL, a daily maintenance dose of 1,000 to 2,000 IU is recommended.
  • Children who are vitamin D deficient require 2000 IU/day of vitamin D3 or 50,000 IU of vitamin D3 once weekly for 6 weeks.
• Serum 25-hydroxy-vitamin D (25OH-D) Levels:
  • Levels should ideally be at least 50 nmol/L for maintaining good skeletal health.
  • Experts recommend levels of 75 nmol/L and above for normal skeletal and muscular structure and function.
  • Evidence suggests that minimum 100 nmol/L of 25OH-D levels are needed to reduce the risk of various health conditions, including certain cancers, cardiovascular disease, infectious diseases, and COVID-19.
  • Optimal levels are considered to be at least 100 nmol/L, ensuring sufficiency for all body systems.
  • Normal range: 75–150 nmol/L.
• Categories of Vitamin D Status by 25OH-D Levels:
  • Severe deficiency: <25 nmol/L
  • Moderate deficiency: 25–<50 nmol/L
  • Insufficiency: 50–<75 nmol/L
  • Sufficiency: 75–<100 nmol/L
  • Optimal levels: 100–<150 nmol/L
  • Increased levels: 150–<250 nmol/L
  • Overdose: ≥250 nmol/L
  • Intoxication: ≥375 nmol/L (including lower levels if hypercalcemia is caused by vitamin D supplements)
• Recommended Vitamin D Doses for Prevention and Treatment:
  • Prophylactic doses for different age groups:
    • Infants: 400–800 IU/day
    • Children: 600–2000 IU/day
    • Teens: 800–2000 IU/day
    • Adults: 1000–4000 IU/day
  • Therapeutic doses for deficiency or insufficiency:
    • Infants to adults: 1000–6000 IU/day for 3 months, with adjustments based on baseline levels and risk factors.
  • In high-risk groups, such as obese individuals or those with malabsorption syndromes, doses may be increased two-fold or three-fold.

Emerging Trends

• Rising Health Consciousness and Preventive Healthcare: People are increasingly focusing on preventive health measures, and vitamin D testing is riding that wave. There’s a heightened awareness about the role vitamin D plays in overall health, spurred by educational efforts and media coverage. This has led more people to monitor their vitamin D levels to prevent potential health issues down the line.
• Advancements in Testing Technologies: The field is benefiting from technological innovations, including the development of quick and easy point-of-care testing kits and more precise methods like LC-MS (Liquid Chromatography-Mass Spectrometry). These technologies offer accurate and reliable results, making it easier for doctors to diagnose and manage conditions related to vitamin D deficiency.
• Integration into Regular Health Checks: Vitamin D testing is becoming a staple in routine health assessments, particularly for at-risk groups like the elderly or those living in areas with limited sunlight. Healthcare professionals are increasingly recommending regular vitamin D tests as part of comprehensive health evaluations.
• Educational Campaigns and Health Initiatives: In regions like North America, health organizations are actively promoting the benefits of vitamin D, which has boosted the uptake of testing services. These campaigns are crucial in educating the public and encouraging them to take vitamin D deficiency seriously​.
• Expansion in Emerging Markets: The vitamin D testing market is set to expand significantly in developing regions such as the Asia-Pacific. This growth is driven by improvements in healthcare infrastructure, increased access to health services, and a rising middle class that is more health-conscious. These factors combine to create a fertile ground for the adoption of advanced health testing services​.

Use Cases

• Assessment of Nutritional Status: Vitamin D testing is used to assess an individual’s vitamin D levels, indicating their nutritional status. Low vitamin D levels may suggest a deficiency or insufficiency, which can impact bone health and overall well-being. Studies indicate that approximately 40% of the adult population in the United States has vitamin D deficiency or insufficiency, highlighting the significance of testing for nutritional evaluation.
• Bone Health Evaluation: Vitamin D is crucial for maintaining bone health. Testing helps identify individuals with low vitamin D levels, who may be at a higher risk of conditions like osteoporosis and fractures. Adequate vitamin D levels are essential for bone mineralization. Research shows that individuals with the lowest vitamin D levels have a 30% higher risk of cardiovascular disease compared to those with higher levels.
• Monitoring Treatment: Regular testing allows healthcare professionals to monitor the effectiveness of vitamin D supplementation or lifestyle adjustments in individuals with deficiency or insufficiency. It helps ensure that vitamin D levels reach and remain within the optimal range for improved health outcomes.
• Risk Assessment for Chronic Diseases: Low vitamin D levels have been associated with an increased risk of chronic diseases such as cardiovascular diseases, diabetes, and certain cancers. Testing enables the identification of individuals at higher risk, prompting further evaluation and potentially early intervention strategies.
• Monitoring Sunlight Exposure: Vitamin D is synthesized in the skin upon exposure to sunlight. Testing helps individuals monitor their vitamin D levels in relation to their sunlight exposure. This information guides them in adjusting sun exposure or using supplements to maintain optimal vitamin D levels. Globally, an estimated 1 billion people have vitamin D deficiency or insufficiency due to inadequate sunlight exposure.
• Athlete Performance Optimization: Optimizing vitamin D levels in athletes may enhance physical performance and reduce the risk of injuries. Testing allows athletes and coaches to determine if vitamin D levels are within the optimal range for peak performance. Studies indicate that athletes with higher vitamin D levels exhibit improved muscle function and have a reduced risk of stress fractures.

Key Players Analysis

• Abbott Laboratories has been a key player in the Vitamin D testing market, launching the first Vitamin D deficiency testing service in collaboration with BP Healthcare Group. This service is designed as a simple, non-invasive blood test with results delivered in a few days, addressing vital health concerns like osteoporosis and rickets related to Vitamin D deficiency​​. Abbott operates in a global market that continues to grow, driven by increased awareness of Vitamin D’s health benefits and technological advancements in testing methods such as LC-MS, which is noted for its high accuracy​.
• Beckman Coulter, Inc. significantly contributes to the vitamin D testing market with its Access 25(OH) Vitamin D Total assay, an advanced solution that streamlines vitamin D testing by detecting both D2 and D3 forms, thus eliminating the need for multiple tests. This assay, compatible with the company’s Access and UniCel DxI series of immunoassay systems, meets stringent standards including alignment with the Ghent University standard for vitamin D measurement. This capability ensures fast, accurate assessments that are critical for determining bone health and managing vitamin D deficiencies.
• F. Hoffmann-La Roche Ltd is a prominent player in the vitamin D testing market, mainly through its Elecsys Vitamin D total II assay. This product is renowned for its high precision and consistency, directly traceable to official reference methods, ensuring reliable patient results. Roche’s diagnostic solutions are integral to healthcare decision-making, supporting both disease management and preventive care. The company’s commitment to innovation in diagnostics underscores its role in advancing healthcare outcomes globally​.
• Danaher Corporation plays a significant role in the global Vitamin D testing market, offering a range of diagnostic solutions that address the increasing demand for Vitamin D testing due to rising deficiencies and the growing popularity of preventive healthcare. As one of the key players, Danaher contributes to the market alongside other major companies, addressing the needs for accurate and efficient Vitamin D testing technologies across various regions. The Vitamin D testing market itself is expanding at a notable pace, driven by the escalating awareness of Vitamin D’s critical role in bone health and overall well-being​.
• Siemens Healthcare GmbH plays a significant role in the Vitamin D testing sector, offering innovative solutions for accurate diagnosis and monitoring. Through advanced technologies and reliable testing kits, Siemens contributes to enhancing healthcare outcomes by enabling efficient detection of Vitamin D deficiencies. Market data indicates a steady increase in demand for such testing services, driven by growing awareness of Vitamin D’s crucial role in health and well-being, positioning Siemens as a key player in this essential healthcare niche.
• BIOMÉRIEUX is a prominent player in the competitive landscape of the Vitamin D testing market, which is expected to grow significantly in the coming years. As a part of its strategic market activities, BIOMÉRIEUX, along with other leading companies like Abbott Laboratories and Thermo Fisher Scientific, focuses on advancements and expansions in this sector to meet the rising global demand driven by increasing awareness of Vitamin D’s health benefits​.
• DiaSorin S.p.A. is a prominent entity in the global vitamin D testing market, renowned for its development, manufacture, and marketing of reagent kits used in in-vitro diagnostic assays. With a significant market share, particularly in the U.S., the company is a leader in the immunodiagnostics field, especially in vitamin D testing. Despite facing a 25.9% decline in sales of vitamin D testing products in 2022, DiaSorin remains a key player due to its extensive range of tests and strategic expansions, such as its launch of the CLIA 25 OH Vitamin D test in Japan, which marked a significant step in expanding its global footprint​.
• Quest Diagnostics Incorporated plays a significant role in the vitamin D testing market through its comprehensive diagnostics services. They offer specific tests such as the QuestAssureD™ 25-Hydroxyvitamin D and the Vitamin D, 25-Hydroxy, Total Immunoassay, which measure serum 25-OH vitamin D concentrations to assess the vitamin’s activity in the body. These tests are crucial for detecting vitamin D deficiency and ensuring adequate vitamin D levels for overall health.
• Thermo Fisher Scientific Inc. has enhanced the Vitamin D testing process with its Cascadion SM Clinical Analyzer, now available in the U.S. This system uses the Cascadion SM 25-Hydroxy Vitamin D assay to provide precise, traceable measurements of Vitamin D_2 and D_3. The technology simplifies vitamin D testing in clinical settings by combining sample processing, LC separation, and MS detection into a fully automated, user-friendly system. This advancement aligns with CDC standards and is FDA-listed, ensuring both reliability and ease of use for healthcare professionals.
• Tosoh Bioscience, Inc. has developed the ST AIA-PACK 25-OH Vitamin D assay, utilized on Tosoh AIA System Analyzers for the quantitative measurement of total 25-hydroxyvitamin D levels in human serum and plasma. This product features a broad assay range and a 90-day calibration stability, enabling effective vitamin D sufficiency testing in medical laboratories. The technology ensures minimal waste and enhances cost efficiency, positioning Tosoh as a key player in the vitamin D testing market.

Conclusion

In conclusion, the Vitamin D Testing Market is poised for substantial growth, fueled by heightened global awareness of vitamin D’s health implications and technological advancements in diagnostic testing. The increasing incidence of diseases associated with vitamin D deficiency and the growing trend toward preventive healthcare continue to drive demand for accurate and accessible vitamin D testing solutions. Major market players are innovating and expanding their product portfolios to meet the needs of a diverse client base, emphasizing the significance of vitamin D in maintaining overall health and well-being. As the market evolves, it is expected to witness significant developments that will enhance diagnostic capabilities and healthcare outcomes globally.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

Request a Sample Download PDF